Literature DB >> 3606082

Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin.

R Fernández-Roblas, S Prieto, M Santamaría, C Ponte, F Soriano.   

Abstract

The in vitro activities of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and from healthy skin of hospitalized patients were studied. Ciprofloxacin, ofloxacin, norfloxacin, vancomycin, and teicoplanin were very active against these microorganisms. There were no significant differences in susceptibility between clinical and colonizing isolates.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3606082      PMCID： PMC174843          DOI： 10.1128/AAC.31.5.821

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  7 in total

1.  Characterization and identification of 95 diphtheroid (group JK) cultures isolated from clinical specimens.

Authors:  P S Riley; D G Hollis; G B Utter; R E Weaver; C N Baker
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

2.  Skin colonization with antibiotic-resistant (JK group) and antibiotic-sensitive lipophilic diphtheroids in hospitalized and normal adults.

Authors:  E L Larson; K J McGinley; J J Leyden; M E Cooley; G H Talbot
Journal:  J Infect Dis       Date:  1986-04       Impact factor: 5.226

3.  [Endocarditis caused by Corynebacterium (report of 2 cases and review of the literature)].

Authors:  J Vilaseca; J M Martínez Vázquez; J Angel; F Fernández; C Villanueva; J Guardia; J Tornos; R Bacardi
Journal:  Rev Clin Esp       Date:  1973-04-30       Impact factor: 1.556

4.  Antimicrobial susceptibility of Corynebacterium group D2.

Authors:  M Santamaría; C Ponte; I Wilhelmi; F Soriano
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

5.  Pathogenic JK group corynebacteria and their similarity to human cutaneous lipophilic diphtheroids.

Authors:  K J McGinley; J N Labows; J M Zeckman; K M Nordstrom; G F Webster; J J Leyden
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

6.  In vitro and in vivo study of stone formation by Corynebacterium group D2 (Corynebacterium urealyticum).

Authors:  F Soriano; C Ponte; M Santamaría; C Castilla; R Fernández Roblas
Journal:  J Clin Microbiol       Date:  1986-04       Impact factor: 5.948

7.  Corynebacterium group D2 as a cause of alkaline-encrusted cystitis: report of four cases and characterization of the organisms.

Authors:  F Soriano; C Ponte; M Santamaria; J M Aguado; I Wilhelmi; R Vela; L C Delatte
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948
  7 in total
  20 in total

1.  Increasing incidence of Corynebacterium group D2 strains resistant to norfloxacin and ciprofloxacin.

Authors:  F Soriano; R Fernández-Roblas; J Zapardiel; J L Rodríguez-Tudela; P Avilés; M Romero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

2.  Comparison of the agar dilution, tube dilution, and broth microdilution susceptibility tests for determination of teicoplanin MICs.

Authors:  M T Kenny; J K Dulworth; M A Brackman
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

3.  In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics.

Authors:  A Philippon; F Bimet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-12       Impact factor: 3.267

4.  In vitro activity of 79 antimicrobial agents against Corynebacterium group D2.

Authors:  J A García-Rodriguez; J E García Sánchez; J L Muñoz Bellido; T Nebreda Mayoral; E García Sánchez; I García García
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

5.  Skin colonization by Corynebacterium groups D2 and JK in hospitalized patients.

Authors:  F Soriano; J L Rodriguez-Tudela; R Fernández-Roblas; J M Aguado; M Santamaría
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

6.  Emergence of urea-splitting multi-resistant coryneform bacteria (Corynebacterium group D2) as pathogens.

Authors:  F Soriano
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

7.  Successful treatment of Corynebacterium urealyticum encrusting cystitis with systemic and intravesical antimicrobial therapy.

Authors:  Oriana Raab; Romain Béraud; Karen M Tefft; C Anne Muckle
Journal:  Can Vet J       Date:  2015-05       Impact factor: 1.008

8.  Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents.

Authors:  F Soriano; J Zapardiel; E Nieto
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

9.  Urinary tract infection with Corynebacterium urealyticum in South Africa.

Authors:  D Walkden; K P Klugman; S Vally; P Naidoo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

Review 10.  Infections caused by antibiotic-resistant Corynebacterium group D2.

Authors:  F Soriano; R Fernández-Roblas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-06       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.